<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>With the exception of the catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), the management of patients with APS has been largely supportive aiming at avoiding a recurrent thrombotic event; it is noteworthy that data concerning therapy targeting the triggering factor (the antiphopsholipid antibodies) are scarce </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of APS manifested as recurrent fetal losses, <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> with concomitant <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> successfully treated with the combination of plasmapheresis and anti-CD20 antibody </plain></SENT>
</text></document>